Can-Fite BioPharma Ltd. (CANF)

Can-Fite BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	21	9	17	26	27	4
Market Cap Growth	-65.30%	-46.11%	-35.61%	-5.65%	517.40%	-78.81%
Enterprise Value	21	0	9	7	19	2
PE Ratio	-	-1.18	-1.64	-2.05	-1.90	-0.35
PS Ratio	32.06	12.09	20.58	30.35	35.96	2.19
PB Ratio	13.86	1.44	3.73	1.80	4.52	1.82
P/FCF Ratio	-1.06	-1.06	-1.54	-2.62	-2.27	-0.40
P/OCF Ratio	-1.06	-1.06	-1.54	-2.63	-2.27	-0.40
EV/Sales Ratio	28.77	0.13	10.79	8.05	25.11	0.87
EV/EBITDA Ratio	-0.01	-0.01	-0.87	-0.55	-1.33	-0.14
EV/EBIT Ratio	-0.01	-0.01	-0.86	-0.54	-1.33	-0.14
EV/FCF Ratio	-0.01	-0.01	-0.81	-0.70	-1.58	-0.16
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.03
Debt / EBITDA Ratio	-0.01	-0.01	-0.01	-0.01	0.00	-0.01
Debt / FCF Ratio	0.00	0.00	-0.01	-0.01	-0.01	-0.01
Quick Ratio	4.42	4.42	3.19	7.01	6.57	1.12
Current Ratio	4.91	4.91	3.66	7.35	7.41	2.18
Asset Turnover	0.08	0.08	0.06	0.06	0.09	0.20
Return on Equity (ROE)	-142.50%	-142.50%	-107.90%	-145.20%	-339.20%	-238.40%
Return on Assets (ROA)	-79.20%	-79.20%	-68.90%	-88.00%	-163.20%	-122.90%
Return on Capital (ROIC)	-130.43%	-130.43%	-222.67%	-88.53%	-230.24%	-477.04%
Earnings Yield	-32.05%	-84.99%	-61.03%	-48.73%	-52.64%	-284.10%
FCF Yield	-9.75%	-93.99%	-64.85%	-38.13%	-44.06%	-249.49%
Buyback Yield / Dilution	-131.13%	-56.71%	-47.49%	-54.31%	-317.19%	-120.84%
Total Shareholder Return	-131.13%	-56.71%	-47.49%	-54.31%	-317.19%	-120.84%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).